{"product_id":"iatrogenicity-causes-and-consequences-of-iatrogenesis-in-cardiovascular-medicine-9780813586410","title":"Iatrogenicity  Causes and Consequences of","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book addresses consequences on the cardiovascular system that arise from iatrogenesis— the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one’s expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eTABLE OF CONTENTS\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e Part I: MEDICAL HARM \u003c\/p\u003e\u003cp\u003e 1.      The Concept and Spectrum of \"Iatrogenicity\" \u003c\/p\u003e\u003cp\u003e\u003ci\u003eI. Gussak and J. Kostis\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 2.      Iatrogenicity:  Definition, History and Modern Context \u003c\/p\u003e\u003cp\u003e\u003ci\u003eM. Gussak, I. Gussak, and J. Kostis\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 3.      Epidemiology and Public Health Aspects and Implications:  Regulatory, Legal and Ethical Dimensions of Iatrogenicity \u003c\/p\u003e\u003cp\u003e\u003ci\u003eS. Jones and M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 4.      Risk Management:  The Medical Center Administration Perspective \u003c\/p\u003e\u003cp\u003e\u003ci\u003eS. Jones and M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 5.      Iatrogenicity from the Patient's Perspective \u003c\/p\u003e\u003cp\u003e\u003ci\u003eJ. Dobrzynski, S. Jones, and M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 6.      A Naturopathic Perspective on Iatrogenesis \u003c\/p\u003e\u003cp\u003e\u003ci\u003eC. Fleetwood\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e Part II:  IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY OF NON-CARDIAC DRUGS \u003c\/p\u003e\u003cp\u003e 7.      Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes \u003c\/p\u003e\u003cp\u003e\u003ci\u003eI. Gussak, G. Yan, A. Jahangir, and J. Kostis\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 8.      Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death \u003c\/p\u003e\u003cp\u003e\u003ci\u003eA. Narichania, Y. Yokoyama, and W.K. Shen\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 9.      Chemotherapy-Induced Cardiomyopathies \u003c\/p\u003e\u003cp\u003e\u003ci\u003eE. Birati and B. Jessup\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 10.  Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of Hypertension \u003c\/p\u003e\u003cp\u003e\u003ci\u003eT. Giles, G. Sander, I. Gussak, and J. Kostis\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 11.  Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes \u003c\/p\u003e\u003cp\u003e\u003ci\u003eR. Kalaitzidis and G. Bakris\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 12.  Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and Non-Cardiac Toxicities: Antihypertensive Agents and Biologics \u003c\/p\u003e\u003cp\u003e\u003ci\u003eE. Hermes-Desantis and J. Barone\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 13.  Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia \u003c\/p\u003e\u003cp\u003e\u003ci\u003eC. Thomopoulos and T. Makris\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 14.  Women and Iatrogenic Cardiovascular Disease:  Menopausal Estrogen as the Prime Suspect \u003c\/p\u003e\u003cp\u003e\u003ci\u003eG. Bachmann, M. Rees, and N. Phillips\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 15.  Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic, Antiplatelet, and Antithrombotic Agents \u003c\/p\u003e\u003cp\u003e\u003ci\u003eC. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 16.  Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System \u003c\/p\u003e\u003cp\u003e\u003ci\u003eK. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 17.  Iatrogencity and Antianginal Drugs \u003c\/p\u003e\u003cp\u003e\u003ci\u003eA. Moreyra and W.J. Kostis\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 18.  Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand? \u003c\/p\u003e\u003cp\u003e\u003ci\u003eR. Kumar\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 19.  Cardiovascular Iatrogenicity in Older Adults \u003c\/p\u003e\u003cp\u003e\u003ci\u003eA. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #. Malone\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e Part III:  IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES \u003c\/p\u003e\u003cp\u003e 20.  Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in Interventional Cardiology \u003c\/p\u003e\u003cp\u003e\u003ci\u003eC. Dösch, D. Loßnitzer, T. Papavassiliu\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 21.  Iatrogenicity Associated with Interventional Treatment Modalities \u003c\/p\u003e\u003cp\u003e\u003ci\u003eN.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 22.  Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive Cardiovascular Interventions, Devices and Surgeries \u003c\/p\u003e\u003cp\u003e\u003ci\u003eM. Behnes, T. Becher, S. Baumann, and I. Akin\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 23.  Iatrogenic Aspects in Cardiac Electrophysiology \u003c\/p\u003e\u003cp\u003e\u003ci\u003eB. Rudic, E. Tülümen, and V. Liebe\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 24.  Iatrogenic Aspects in Cardiac Device Therapy \u003c\/p\u003e\u003cp\u003e\u003ci\u003eS. Röger and J. Kuschyk\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 25.  Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities \u003c\/p\u003e\u003cp\u003e\u003ci\u003eM.S. Nolledo, P. Lerma and T.V. Santiago\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e Part IV:  IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE MODIFICATIONS \u003c\/p\u003e\u003cp\u003e 26.  Professional Athletes \u003c\/p\u003e\u003cp\u003e\u003ci\u003eG. Mancia\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 27.  Sports Cardiology \u003c\/p\u003e\u003cp\u003e\u003ci\u003eG. Campanile\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 28.  Dangers of Lifestyle Modification Advice \u003c\/p\u003e\u003cp\u003e\u003ci\u003eG. Campanile\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e Part V:  IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE \u003c\/p\u003e\u003cp\u003e 29.  Safety of Over-the-Counter ‘Natural Substances’ and Vitamins:  Side-effects and Contraindications \u003c\/p\u003e\u003cp\u003e\u003ci\u003eS. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e 30.  Interactions Between Supplements and Prescription Medications \u003c\/p\u003e\u003cp\u003e\u003ci\u003eS. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir\u003c\/i\u003e\u003c\/p\u003e\u003cp\u003e Acknowledgments \u003c\/p\u003e\u003cp\u003e Index \u003c\/p\u003e","brand":"Rutgers University Press","offers":[{"title":"Default Title","offer_id":49405792715095,"sku":"9780813586410","price":105.4,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780813586410.jpg?v=1730493637","url":"https:\/\/bookcurl.com\/products\/iatrogenicity-causes-and-consequences-of-iatrogenesis-in-cardiovascular-medicine-9780813586410","provider":"Book Curl","version":"1.0","type":"link"}